Video
Become a Member to Save

Dr Ariharan Anantharachagan's Post-ESID 2022 takeaways

Dr Ariharan Anantharachagan, Consultant Immunologist at Lancashire Teaching Hospitals, Preston with Dr Suzy Elcombe, Consultant Immunologist at The Royal Victoria Infirmary, Newcastle-upon-Tyne, will be discussing his two chosen topics from ESID 2022 and how these might impact on the management and care of immunodeficiency.

Topics chosen:

1. IFNG Autoantibodies and Susceptibility to Mycobacteria; Steven M Holland

2. Meet-the-Expert 1 - Early vs. Late HSCT – Wait for Symptoms or Trust Genetics? Jenny Lingman-Framme, Emma Morris, Andrew Gennery

Primary Immunodeficiency
Allied Professional
Consultant
FY1/FY2
General Practitioner
Nurse
Specialist Nurse
ST3+
Clinical Immunology
All Content
Contribute

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Takeda UK Ltd. at: AE.GBR-IRL@takeda.com

Rare Disease Hub is for UK healthcare professionals only. This website has been initiated and developed by Takeda.

Copyright © 2022 Takeda UK Ltd.

 

C-ANPROM/GB/IG/0205

January 2023